You can post a question only up to 7 days from the date of the webinar.
You can continue to post comments and stay informed, compliant, and profitable.
Close
This session has expired.
Register for our upcoming webinars & continue to get coding, compliance & reimbursement updates.
Close

Post

Vote
0
0 Followers Follow
Posted By NISREEN on 10-21-2020, 20:58:23 in Oncology
When billing part B for a privet oncology office, How to bill for ( rituximab-abbs, biosimilar, (truxima 10 mg) Q5115.
if the patient requires 750mg we used the 500mg vile NDC 63459-0104-50 that's 50 billing units and 3 viles of the 100 mg 63459-0103-10 , we used 250mg are left with 50 mg wast.
how to bill the wast in this scenario
Q5115 50 units 63459-0104-50
Q5115 25 units 63459-0103-10
Q5115 5 units with JW modifier 63459-0103-10
Comments (0)
Do you want to remove this attachment from this post?
Yes No
Do you want to add this specialty to your selected specialty list?
Yes No
To comment, please register for any of our webinars. Click here to register for our upcoming webinars.
Close
This comment will be permanently deleted. Do you still want to continue?
Yes No
Do you want to remove this comment from this discussion?
Yes No
Do you want to block this user from participating in this discussion?
Yes No
Do you want to allow this user to participate in this discussion?
Yes No
This post will not be available for further discussion/comments if deleted. Do you still want to continue?
Yes No